MedPath

Tiamulix 10% Premix Powder

Registration Number: MAL11120050HA

Approved
Approval ID

701bf558f5dfc9a1

Registration Number

MAL11120050HA

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types3 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (3)

25.00 mcg/mLAvailable
Package Size: 25.00 mcg/mL
Status: NPRA Approved
500.00 mcg/mLAvailable
Package Size: 500.00 mcg/mL
Status: NPRA Approved
1000.00 mcg/mLAvailable
Package Size: 1000.00 mcg/mL
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

TIAMULIN HYDROGEN FUMARATEActive
Monograph: tiamulin hydrogen fumarate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Tiamulix 10% Premix Powder - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform